Mechanisms of Divalent Metal Toxicity in Affective Disorders
Overview
Affiliations
Metals are required for proper brain development and play an important role in a number of neurobiological functions. The divalent metal transporter 1 (DMT1) is a major metal transporter involved in the absorption and metabolism of several essential metals like iron and manganese. However, non-essential divalent metals are also transported through this transporter. Therefore, altered expression of DMT1 can modify the absorption of toxic metals and metal-induced toxicity. An accumulating body of evidence has suggested that increased metal stores in the brain are associated with elevated oxidative stress promoted by the ability of metals to catalyze redox reactions, resulting in abnormal neurobehavioral function and the progression of neurodegenerative diseases. Metal overload has also been implicated in impaired emotional behavior, although the underlying mechanisms are not well understood with limited information. The current review focuses on psychiatric dysfunction associated with imbalanced metabolism of metals that are transported by DMT1. The investigations with respect to the toxic effects of metal overload on behavior and their underlying mechanisms of toxicity could provide several new therapeutic targets to treat metal-associated affective disorders.
Liu J, Beard J, Hussain S, Sayes C Heliyon. 2024; 10(22):e40481.
PMID: 39634418 PMC: 11615481. DOI: 10.1016/j.heliyon.2024.e40481.
Protective role of hesperetin in Drosophila melanogaster model of ferrous sulphate-induced toxicity.
Asejeje F, Asejeje G, Ogunro O, Adedara A, Abolaji A BMC Pharmacol Toxicol. 2024; 25(1):70.
PMID: 39334451 PMC: 11438368. DOI: 10.1186/s40360-024-00792-0.
Particulate matter from car exhaust alters function of human iPSC-derived microglia.
Jantti H, Jonk S, Gomez Budia M, Ohtonen S, Fagerlund I, Fazaludeen M Part Fibre Toxicol. 2024; 21(1):6.
PMID: 38360668 PMC: 10870637. DOI: 10.1186/s12989-024-00564-y.
Common and Trace Metals in Alzheimer's and Parkinson's Diseases.
Doroszkiewicz J, Farhan J, Mroczko J, Winkel I, Perkowski M, Mroczko B Int J Mol Sci. 2023; 24(21).
PMID: 37958705 PMC: 10649239. DOI: 10.3390/ijms242115721.
Cojocaru K, Luchian I, Goriuc A, Antoci L, Ciobanu C, Popescu R Antioxidants (Basel). 2023; 12(3).
PMID: 36978905 PMC: 10045078. DOI: 10.3390/antiox12030658.